Actively Recruiting
Evaluating a Combined Polypill of Four Heart Failure Medications Versus Usual Care in Adults with Reduced Ejection Fraction Heart Failure in Sri Lanka
Led by Washington University School of Medicine · Updated on 2026-10-22
1672
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating adults in Sri Lanka with heart failure with reduced ejection fraction HFrEF to assess how an HFrEF polypill strategy affects the combined rate of cardiovascular death and repeated heart failure hospitalizations compared to usual care. The study evaluates this over at least 12 months of follow-up and includes secondary outcomes such as mortality rates, heart function changes via echocardiogram, and quality of life measures. Participants will be randomly assigned to two groups one receives usual care with guideline-directed medications dispensed at no charge when available, while the other receives a combined polypill containing bisoprolol, losartan, eplerenone, and dapagliflozin in three possible dose strengths. The polypill dose will be adjusted during scheduled visits to reach the highest tolerated dose, aiming for the strongest dose by study end. During the study, participants undergo regular visits at 1, 3, 6, 9, and 12 months and every 3 months thereafter, averaging 18 months total. Researchers will monitor heart function, biomarker levels, quality of life questionnaires, medication adherence, and safety outcomes including adverse events and laboratory measures like potassium and creatinine levels. The study includes detailed assessments to evaluate treatment persistence, dose optimization, and overall health impact over time.
CONDITIONS
Brief Title
HFrEF Polypill in Sri Lanka RCT
Research Team
A
Anubha Agarwal, MD MSc
A
Asita de Silva, MBBS DPhil FRCP
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here